KREBSBIO.NS

Krebs Biochemicals & Industries Limited [KREBSBIO.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

KREBSBIO.NS Stock Summary

Top 10 Correlated ETFs

KREBSBIO.NS

Top 10 Correlated Stocks

KREBSBIO.NS

In the News

KREBSBIO.NS Financial details

Company Rating
-
Market Cap
1.54B
Income
-208.21M
Revenue
499.09M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
210
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
-8
Forward P/E
-
PEG
1.5
P/S
3.73
P/B
-1.58
P/C
-
P/FCF
-
Quick Ratio
0.05
Current Ratio
0.3
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-9.66
EPS next Y
-
EPS next Q
-
EPS this Y
-44.55%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.98%
Revenue last 5Y
7.02%
Revenue Q/Q
-12.85%
EPS Q/Q
39.16%
-
-
-
-
SMA20
-3.37%
SMA50
10.26%
SMA100
-12.24%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
22%
ROC
-0.14%
Gross Margin
84%
Oper. Margin
-37%
Profit Margin
-46%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
59.2-93.95
52W High
-11.06%
52W Low
+40.19%
RSI
45
Rel Volume
0.26
Avg Volume
17.99K
Volume
4.59K
Perf Week
-6.25%
Perf Month
8.19%
Perf Quarter
-8.58%
Perf Half Y
-12.89%
-
-
-
-
Beta
0.467
-
-
Volatility
1.42%, 6.49%
Prev Close
-1.03%
Price
82.71
Change
-2.69%

Something similar

Top by Market Cap
ABEA.DE
VOO
V
DHR-PB
APC.DE
Top Correlated ETFs
LIVP.L
XAD6.MI
ESVR.MI
SIUS.L
Top Correlated Stocks
DLF.NS
GROBTEA.NS
CUBEXTUB.NS
NILAINFRA.NS
SUNTECK.NS
Similar Market Cap
NKLA
603192.SS
STC
SNEX
EQC

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 17.99K
  • Market Capitalization 1.54B
  • Employee 210
  • CEO Mr. Jitendra Rameshchandra Shah
  • Headquarters Hyderabad,IN
  • IPO Date 2016-10-27
  • Website https://krebsbiochem.com

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.